Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
<div><p>Immunotherapy has emerged as the fifth pillar of cancer treatment alongside surgery, radiotherapy, chemotherapy, and targeted therapy. Immune checkpoint inhibitors are the current superheroes of immunotherapy, unleashing a patient’s own immune cells to kill tumors and revolutioni...
محفوظ في:
| المؤلف الرئيسي: | Remy Thomas (702843) (author) |
|---|---|
| مؤلفون آخرون: | Ghaneya Al-Khadairi (14153274) (author), Julie Decock (44558) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
حسب: Said Dermime (79420)
منشور في: (2021) -
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
حسب: Said Dermime (79420)
منشور في: (2021) -
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
حسب: Mike Mason (18007491)
منشور في: (2024) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
حسب: Reem Saleh (3513056)
منشور في: (2019) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
حسب: Reem Saleh (3513056)
منشور في: (2019)